Armata Pharmaceuticals ARMP
NYSE ARMP
$3.50 +0.20 (+6.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Armata Pharmaceuticals (ARMP) Cash & Current Investments (2013 - 2026)

Updated

Armata Pharmaceuticals' Cash & Current Investments came in at $24 million for Q2 2026, up 454.5% from $4.33 million a year earlier and up 400.0% from the prior quarter.

Analysis

Armata Pharmaceuticals (ARMP) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Armata Pharmaceuticals' Cash & Current Investments was $8.69 million, down 6.5% from FY2024.

  • Cash & Current Investments has declined in each of the last three years, with a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $9.29 million in FY2024 (-31.3%), $13.52 million in FY2023 (-8.9%), $14.85 million in FY2022 (+44.4%) and $10.29 million in FY2021 (+6.6%).
  • The Q2 2026 figure represents the highest quarterly Cash & Current Investments since Q2 2024.
  • Year-over-year, Cash & Current Investments increased in 1 of the last eight quarters, with growth averaging 20.4%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 454.5%), and the weakest in Q2 2025 (a decline of 83.6%).
  • Business Quant data shows ARMP's Cash & Current Investments at $4.8 million (Q1 2026), $8.69 million (Q4 2025) and $14.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Armata Pharmaceuticals 130.01 Mn 77.72 Mn - 24.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.00 Mn
Mar 31, 2026 4.80 Mn
Dec 31, 2025 8.69 Mn
Sep 30, 2025 14.80 Mn
Jun 30, 2025 4.33 Mn
Mar 31, 2025 11.69 Mn
Dec 31, 2024 9.29 Mn
Sep 30, 2024 17.14 Mn
Jun 30, 2024 26.41 Mn
Mar 31, 2024 37.86 Mn
Dec 31, 2023 13.52 Mn
Sep 30, 2023 23.96 Mn
Jun 30, 2023 12.46 Mn
Mar 31, 2023 25.11 Mn
Dec 31, 2022 14.85 Mn
Sep 30, 2022 25.38 Mn
Jun 30, 2022 36.98 Mn
Mar 31, 2022 46.41 Mn
Dec 31, 2021 10.29 Mn
Sep 30, 2021 12.08 Mn
API Access

Armata Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARMP&period=max&api_key=YOUR_API_KEY